Who invested in Imprimis Pharmaceuticals?
Imprimis Pharmaceuticals's investors include Life Sciences Alternative Funding.
United States · Funded startup
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$23Mraised across 2 rounds since 2012, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $500K sold, first sale Jan 2015
No investor was named in the report.
Reported by sec.govSEC filing: $7.9M sold, first sale Apr 2012
Imprimis Pharmaceuticals's investors include Life Sciences Alternative Funding.
Imprimis Pharmaceuticals has raised $23M across 2 rounds since 2012.
Imprimis Pharmaceuticals's most recent round was a Debt of $15M in May 2015.
Its most recent round, $15M in May 2015, is also its largest on record.
Imprimis Pharmaceuticals's first round on record, in May 2015, was backed by Life Sciences Alternative Funding.
Imprimis Pharmaceuticals's latest named round is a Debt, in May 2015.
Imprimis Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.